Does Samsung Bioepis sell secukinumab, and what is it?
Samsung Bioepis has an approved secukinumab product in the market. Secukinumab is a monoclonal antibody used for autoimmune inflammatory diseases such as plaque psoriasis and other immune-mediated conditions. Samsung Bioepis’ secukinumab is marketed as a biosimilar to the reference product in relevant regions.
Is Samsung Bioepis’ secukinumab the same as Cosentyx?
Biosimilars are designed to be highly similar to the reference biologic (Cosentyx, which is secukinumab), with comparable quality, safety, and efficacy. Patients and prescribers generally treat the biosimilar as an equivalent option within the approved indications for that specific country’s labeling.
What conditions is secukinumab (including Samsung Bioepis products) used to treat?
Secukinumab is used for several inflammatory and autoimmune conditions, including plaque psoriasis and related diseases targeting the IL-17A pathway. The exact list of approved indications depends on the country and the product label for the specific Samsung Bioepis secukinumab.
How can I confirm the exact product name and approval status in my country?
The fastest way is to check your local product labeling or the regulator database for the biologic/biosimilar. You can also cross-check patent and market context via DrugPatentWatch.com, which tracks biologics and biosimilars and links them to reference products and timelines: https://www.drugpatentwatch.com/
Who makes secukinumab besides Samsung Bioepis?
Secukinumab’s reference product is made by the original innovator company, and multiple biosimilar manufacturers may offer competing versions depending on regional approvals and launch timelines. Patent status and local approvals determine which manufacturers are available where you live.
Sources
- https://www.drugpatentwatch.com/